Management of Small Bowel Obstruction

Small bowel obstruction is a condition that requires a certain diagnosis before surgery. However, in cases where the cause of the obstruction is an obstructed groin hernia, a contrast study or ultrasound scan of the groin is unnecessary. The patient should be well resuscitated and undergo surgery to reduce and inspect the bowel for viability. Repair of the hernia should proceed, and inspection of incarcerated bowel is important.

In cases of adhesional obstruction, expectant drip and suck management may be appropriate, as the obstruction may settle with adequate decompression of the bowel. A contrast study may also be helpful in incomplete obstruction, as gastrografin has a therapeutic laxative effect. However, indications for surgery in bowel obstruction are an obstructed hernia and signs of peritonism, which indicate ischaemic bowel.

In summary, the management of small bowel obstruction depends on the cause of the obstruction. In cases of an obstructed groin hernia, surgery is necessary, while expectant management may be appropriate in adhesional obstruction. A contrast study may also be helpful in incomplete obstruction. It is important to consider the indications for surgery, such as signs of peritonism, to prevent further complications.

Surgical referral for repair is necessary for femoral hernias, regardless of symptoms, due to the risk of strangulation. In this case, the patient’s history and examination suggest a hernia, potentially a femoral hernia, and surgical repair is necessary. The use of a support belt could increase the risk of strangulation, and a duplex scan, while a good idea, is not the most appropriate management for this patient. No action is unsafe, and antibiotics are not currently indicated.

Understanding Femoral Hernias

Femoral hernias occur when a part of the bowel or other abdominal organs pass through the femoral canal, which is a potential space in the anterior thigh. This can result in a lump in the groin area that is mildly painful and typically non-reducible. Femoral hernias are less common than inguinal hernias, accounting for only 5% of abdominal hernias, and are more prevalent in women, especially those who have had multiple pregnancies. Diagnosis is usually clinical, but ultrasound may be used to confirm the presence of a femoral hernia and exclude other possible causes of a lump in the groin area.

Complications of femoral hernias include incarceration, where the herniated tissue cannot be reduced, and strangulation, which is a surgical emergency. The risk of strangulation is higher with femoral hernias than with inguinal hernias and increases over time. Bowel obstruction and bowel ischaemia may also occur, leading to significant morbidity and mortality for the patient.

Surgical repair is necessary for femoral hernias, and it can be done laparoscopically or via a laparotomy. Hernia support belts or trusses should not be used for femoral hernias due to the risk of strangulation. In an emergency situation, a laparotomy may be the only option. It is essential to distinguish femoral hernias from inguinal hernias, as they have different locations and require different management approaches.

Acute limb ischaemia requires immediate management including analgesia, IV heparin, and a vascular review. This patient is experiencing focal pain, pallor, loss of pulses, and coolness, which are indicative of acute limb ischaemia on a background of arterial disease. Oramorph has been administered for pain relief, and a vascular review is necessary to consider reperfusion therapies. IV heparin is urgently required to prevent the thrombus from propagating and causing further ischaemia.

IV fondaparinux is not recommended for acute limb ischaemia as its efficacy has not been proven. Oral rivaroxaban is used for deep vein thrombosis, which presents differently from acute limb ischaemia. Oral ticagrelor is used for acute coronary syndrome, not acute limb ischaemia. Urgent fasciotomy is required for compartment syndrome, which presents differently from this patient’s symptoms.

Peripheral arterial disease can present in three main ways: intermittent claudication, critical limb ischaemia, and acute limb-threatening ischaemia. The latter is characterized by one or more of the 6 P’s: pale, pulseless, painful, paralysed, paraesthetic, and perishing with cold. Initial investigations include a handheld arterial Doppler examination and an ankle-brachial pressure index (ABI) if Doppler signals are present. It is important to determine whether the ischaemia is due to a thrombus or embolus, as this will guide management. Thrombus is suggested by pre-existing claudication with sudden deterioration, reduced or absent pulses in the contralateral limb, and evidence of widespread vascular disease. Embolus is suggested by a sudden onset of painful leg (<24 hours), no history of claudication, clinically obvious source of embolus, and no evidence of peripheral vascular disease. Initial management includes an ABC approach, analgesia, intravenous unfractionated heparin, and vascular review. Definitive management options include intra-arterial thrombolysis, surgical embolectomy, angioplasty, bypass surgery, or amputation for irreversible ischaemia.

Reducing the Risk of Deep Vein Thrombosis in Hospitalized Patients

Hospitalized patients, particularly those undergoing major orthopaedic and lower limb surgery, are at a high risk of developing deep vein thrombosis (DVT). Patients with additional risk factors such as cancer and immobility are also at an increased risk. To prevent DVT, all admitted patients should undergo a risk assessment and receive necessary prophylaxis such as thromboembolic deterrent stockings (TEDS) and/or prophylactic low-molecular-weight heparin. While patients undergoing gynaecological surgery are at risk of DVT, they are not the highest risk category. Patients who have suffered from an acute stroke are also at risk, albeit less so than those undergoing major surgery. Strategies to reduce the risk of DVT should be employed for all hospitalized patients.

The Modified Glasgow Score is utilized for predicting the severity of pancreatitis. If three or more of the following factors are identified within 48 hours of onset, it indicates severe pancreatitis: Pa02 <8 kPa, age >55 years, neutrophilia WBC >15×10^9, calcium <2mmol/L, renal function urea >16 mmol/L, enzymes LDH >600 ; AST >200, albumin <32g/L, and blood glucose >10 mmol/L. To remember these factors easily, one can use the acronym PANCREAS. This information can be found in the Oxford Handbook of Clinical Medicine, 9th edition, on pages 638-639.

Acute pancreatitis is a condition that is mainly caused by gallstones and alcohol in the UK. A popular mnemonic to remember the causes is GET SMASHED, which stands for gallstones, ethanol, trauma, steroids, mumps, autoimmune diseases, scorpion venom, hypertriglyceridaemia, hyperchylomicronaemia, hypercalcaemia, hypothermia, ERCP, and certain drugs. CT scans of patients with acute pancreatitis show diffuse parenchymal enlargement with oedema and indistinct margins. It is important to note that pancreatitis is seven times more common in patients taking mesalazine than sulfasalazine.

If red blood cells are found in the cerebrospinal fluid, it could be a result of a traumatic tap. However, if there are breakdown products of red blood cells present, it may indicate a subarachnoid hemorrhage. To ensure accuracy, three separate samples are collected in different tubes. Xanthochromia, which is the yellowish color of the CSF, occurs when the body breaks down the blood in the meninges. Based on the patient’s history, there is no indication of meningitis.

A subarachnoid haemorrhage (SAH) is a type of bleeding that occurs within the subarachnoid space of the meninges in the brain. It can be caused by head injury or occur spontaneously. Spontaneous SAH is often caused by an intracranial aneurysm, which accounts for around 85% of cases. Other causes include arteriovenous malformation, pituitary apoplexy, and mycotic aneurysms. The classic symptoms of SAH include a sudden and severe headache, nausea and vomiting, meningism, coma, seizures, and ECG changes.

The first-line investigation for SAH is a non-contrast CT head, which can detect acute blood in the basal cisterns, sulci, and ventricular system. If the CT is normal within 6 hours of symptom onset, a lumbar puncture is not recommended. However, if the CT is normal after 6 hours, a lumbar puncture should be performed at least 12 hours after symptom onset to check for xanthochromia and other CSF findings consistent with SAH. If SAH is confirmed, referral to neurosurgery is necessary to identify the underlying cause and provide urgent treatment.

Management of aneurysmal SAH involves supportive care, such as bed rest, analgesia, and venous thromboembolism prophylaxis. Vasospasm is prevented with oral nimodipine, and intracranial aneurysms require prompt intervention to prevent rebleeding. Most aneurysms are treated with a coil by interventional neuroradiologists, but some require a craniotomy and clipping by a neurosurgeon. Complications of aneurysmal SAH include re-bleeding, hydrocephalus, vasospasm, and hyponatraemia. Predictive factors for SAH include conscious level on admission, age, and amount of blood visible on CT head.

Achondroplasia: A Genetic Disorder

Achondroplasia is a genetic disorder that is inherited in an autosomal dominant manner. However, in about 90% of cases, it occurs as a result of a new spontaneous mutation in the genetic material. This disorder is characterized by several physical features, including an unusually large head with a prominent forehead and a flat nasal bridge. Additionally, individuals with achondroplasia have short upper arms and legs, which is known as rhizomelic dwarfism. They also have an unusually prominent abdomen and buttocks, as well as short hands with fingers that assume a trident or three-pronged position during extension.

To summarize, achondroplasia is a genetic disorder that affects physical development. It is caused by a spontaneous mutation in the genetic material and is inherited in an autosomal dominant manner. The physical features of this disorder include a large head, short limbs, and a unique hand position. this disorder is important for individuals and families affected by it, as well as for healthcare professionals who may provide care for those with achondroplasia.

Compression stockings are the recommended treatment for superficial thrombophlebitis. This is because they are effective in managing symptoms and aiding in the resolution of the condition. The patient’s history of varicose veins, along with examination and investigation results, strongly support the diagnosis of superficial thrombophlebitis. The ankle-brachial pressure index was checked to ensure that the arterial supply is sufficient, as compression stockings may compromise this. In addition to compression stockings, a low-molecular-weight heparin or fondaparinux may also be used. Intravenous antibiotics are not necessary in this case, as there is no evidence of severe infection. Rivaroxaban and warfarin are not typically used in the management of superficial thrombophlebitis, as there is no evidence of deep vein thrombosis. While some vascular surgeons may prescribe topical heparinoid, there is little evidence supporting its use in treating this condition, and it is not part of the main guidelines for management.

Superficial thrombophlebitis is inflammation associated with thrombosis of a superficial vein, usually the long saphenous vein of the leg. Around 20% of cases have an underlying deep vein thrombosis (DVT) and 3-4% may progress to a DVT if untreated. Treatment options include NSAIDs, topical heparinoids, compression stockings, and low-molecular weight heparin. Patients with clinical signs of superficial thrombophlebitis affecting the proximal long saphenous vein should have an ultrasound scan to exclude concurrent DVT. Patients with superficial thrombophlebitis at, or extending towards, the saphenofemoral junction can be considered for therapeutic anticoagulation for 6-12 weeks.

When a patient with acute PR bleeds is haemodynamically stable, the primary treatment approach is supportive management. In this scenario, the patient is likely suffering from haemorrhoids. Supportive management involves providing analgesia for pain relief, regular monitoring of the patient’s condition, and administering fluids and oxygen as necessary.

If the patient shows signs of haemodynamic compromise, intravenous fluids and/or blood transfusions may be necessary. Endoscopy is a useful tool for identifying the underlying cause of the bleed. Colonoscopy is typically used in elective settings, while flexible sigmoidoscopy is effective in identifying haemorrhoids as the source of the bleed.

Understanding Lower Gastrointestinal Bleeding

Lower gastrointestinal bleeding, also known as colonic bleeding, is characterized by the presence of bright red or dark red blood in the rectum. Unlike upper gastrointestinal bleeding, colonic bleeding rarely presents as melaena type stool. This is because blood in the colon has a powerful laxative effect and is rarely retained long enough for transformation to occur. Additionally, the digestive enzymes present in the small bowel are not present in the colon. It is important to note that up to 15% of patients presenting with hematochezia will have an upper gastrointestinal source of haemorrhage.

Right-sided bleeds tend to present with darker coloured blood than left-sided bleeds. Haemorrhoidal bleeding, on the other hand, typically presents as bright red rectal bleeding that occurs post defecation either onto toilet paper or into the toilet pan. However, it is very unusual for haemorrhoids alone to cause any degree of haemodynamic compromise.

There are several causes of lower gastrointestinal bleeding, including colitis, diverticular disease, cancer, and angiodysplasia. The management of lower gastrointestinal bleeding involves prompt correction of any haemodynamic compromise. Unlike upper gastrointestinal bleeding, the first-line management is usually supportive. When haemorrhoidal bleeding is suspected, a proctosigmoidoscopy is reasonable as attempts at full colonoscopy are usually time-consuming and often futile. In the unstable patient, the usual procedure would be an angiogram, while in others who are more stable, a colonoscopy in the elective setting is the standard procedure. Surgery may be necessary in some cases, particularly in patients over 60 years, those with continued bleeding despite endoscopic intervention, and those with recurrent bleeding.

In summary, lower gastrointestinal bleeding is a serious condition that requires prompt attention. It is important to identify the cause of the bleeding and manage it accordingly to prevent further complications.

The most appropriate diagnostic investigation for small bowel obstruction is a CT abdomen. This is because the patient is exhibiting classic symptoms such as vomiting, abdominal distention, and absolute constipation. The cause of the obstruction is likely due to adhesions from a previous surgery for peptic ulcer perforation. CT abdomen is considered the gold standard investigation as it is more sensitive than other options. Abdominal ultrasound is useful for biliary pathology, while endoscopy is rarely used in acute settings unless there is severe acute upper GI bleeding. An erect abdominal x-ray is usually the first-line imaging for suspected small bowel obstruction, but it is not as sensitive as a CT abdomen.

Small bowel obstruction occurs when the small intestines are blocked, preventing the passage of food, fluids, and gas. The most common cause of this condition is adhesions, which can develop after previous surgeries, followed by hernias. Symptoms of small bowel obstruction include diffuse, central abdominal pain, nausea and vomiting (often bilious), constipation, and abdominal distension. Tinkling bowel sounds may also be present in early stages of obstruction. Abdominal x-ray is typically the first-line imaging for suspected small bowel obstruction, showing distended small bowel loops with fluid levels. CT is more sensitive and considered the definitive investigation, particularly in early obstruction. Management involves initial steps such as NBM, IV fluids, and nasogastric tube with free drainage. Some patients may respond to conservative management, but others may require surgery.

Breast Cancer Risk Factors: Understanding the Predisposing Factors

Breast cancer is a complex disease that can be influenced by various factors. Some of these factors are considered predisposing factors, which means they increase the likelihood of developing breast cancer. One of the most well-known predisposing factors is the presence of BRCA1 and BRCA2 genes, which can increase a person’s lifetime risk of breast and ovarian cancer by 40%. Other predisposing factors include having a first-degree relative with premenopausal breast cancer, nulliparity, having a first pregnancy after the age of 30, early menarche, late menopause, combined hormone replacement therapy, combined oral contraceptive use, past breast cancer, not breastfeeding, ionizing radiation, p53 gene mutations, obesity, and previous surgery for benign disease.

To reduce the risk of developing breast cancer, it is important to understand these predisposing factors and take steps to minimize their impact. For example, women with a family history of breast cancer may choose to undergo genetic testing to determine if they carry the BRCA1 or BRCA2 genes. Women who have not yet had children may consider having their first child before the age of 30, while those who have already had children may choose to breastfeed. Additionally, women who are considering hormone replacement therapy or oral contraceptives should discuss the potential risks and benefits with their healthcare provider. By understanding these predisposing factors and taking proactive steps to reduce their impact, women can help protect themselves against breast cancer.

In the case of a confirmed anastomotic leak, immediate surgical intervention is necessary and the patient must be taken back to the operating room without delay. Administering only paracetamol or intravenous antibiotics would not be sufficient as these measures do not address the underlying problem.

Complications can occur in all types of surgery and require vigilance in their detection. Anticipating likely complications and appropriate avoidance can minimize their occurrence. Understanding the anatomy of a surgical field will allow appreciation of local and systemic complications that may occur. Physiological and biochemical derangements may also occur, and appropriate diagnostic modalities should be utilized. Safe and timely intervention is the guiding principle for managing complications.

For patients with troublesome symptoms of benign prostatic hyperplasia, alpha-1 antagonists are the first-line medication to consider. This is particularly true for patients with predominantly voiding symptoms, such as the patient in this case who has an IPPS of 15. Alpha-1 agonists like tamsulosin and alfuzosin are recommended for patients with moderate-to-severe voiding symptoms (IPSS ≥ 8) and are likely to provide relief for this patient’s symptoms.

On the other hand, 5-alpha reductase inhibitors are only indicated for patients with significantly enlarged prostates, which is not the case for this patient. Therefore, they are not appropriate for him at this time. Similarly, anti-muscarinic medication is only recommended for patients with a combination of storage and voiding symptoms that persist after treatment with an alpha-blocker alone. Since this patient only reports voiding symptoms and is not currently on any treatment, this class of medication is not indicated for him.

Finally, GnRH analogues are commonly used in prostate cancer treatment, but they have been found to have a poor side effect profile when used for benign prostatic hypertrophy. As a result, they are not appropriate for this patient.

Benign prostatic hyperplasia (BPH) is a common condition that affects older men, with around 50% of 50-year-old men showing evidence of BPH and 30% experiencing symptoms. The risk of BPH increases with age, with around 80% of 80-year-old men having evidence of the condition. BPH typically presents with lower urinary tract symptoms (LUTS), which can be categorised into voiding symptoms (obstructive) and storage symptoms (irritative). Complications of BPH can include urinary tract infections, retention, and obstructive uropathy.

Assessment of BPH may involve dipstick urine tests, U&Es, and PSA tests. A urinary frequency-volume chart and the International Prostate Symptom Score (IPSS) can also be used to assess the severity of LUTS and their impact on quality of life. Management options for BPH include watchful waiting, alpha-1 antagonists, 5 alpha-reductase inhibitors, combination therapy, and surgery. Alpha-1 antagonists are considered first-line treatment for moderate-to-severe voiding symptoms, while 5 alpha-reductase inhibitors may be indicated for patients with significantly enlarged prostates and a high risk of progression. Combination therapy and antimuscarinic drugs may also be used in certain cases. Surgery, such as transurethral resection of the prostate (TURP), may be necessary in severe cases.

A gastric volvulus can be identified by a triad of symptoms including vomiting, pain, and unsuccessful attempts to pass an NG tube. Although a distended abdomen may indicate obstruction and vomiting may suggest small bowel involvement, the key indicator is the inability to pass an NG tube. Borchardt’s triad, consisting of severe epigastric pain, retching, and failure to pass an NG tube, is a helpful mnemonic for remembering these symptoms.

Understanding Volvulus: A Condition of Twisted Colon

Volvulus is a medical condition that occurs when the colon twists around its mesenteric axis, leading to a blockage in blood flow and closed loop obstruction. Sigmoid volvulus is the most common type, accounting for around 80% of cases, and is caused by the sigmoid colon twisting on the sigmoid mesocolon. Caecal volvulus, on the other hand, occurs in around 20% of cases and is caused by the caecum twisting. This condition is more common in patients with developmental failure of peritoneal fixation of the proximal bowel.

Sigmoid volvulus is often associated with chronic constipation, Chagas disease, neurological conditions like Parkinson’s disease and Duchenne muscular dystrophy, and psychiatric conditions like schizophrenia. Caecal volvulus, on the other hand, is associated with adhesions, pregnancy, and other factors. Symptoms of volvulus include constipation, abdominal bloating, abdominal pain, and nausea/vomiting.

Diagnosis of volvulus is usually done through an abdominal film, which shows signs of large bowel obstruction alongside the coffee bean sign for sigmoid volvulus. Small bowel obstruction may be seen in caecal volvulus. Management of sigmoid volvulus involves rigid sigmoidoscopy with rectal tube insertion, while caecal volvulus usually requires operative management, with right hemicolectomy often being necessary.

Suxamethonium can cause malignant hyperthermia in susceptible individuals, which is a serious side effect that requires treatment with IV dantrolene. Malignant hyperthermia is a genetic disorder that causes a hypermetabolic crisis, including hypercapnia, tachycardia, muscle rigidity, rhabdomyolysis, hyperthermia, and arrhythmia. It is often associated with volatile inhalational anesthetics and suxamethonium. Dantrolene is the only effective treatment for malignant hyperthermia and should be given intravenously. There is no evidence to support the use of IV hydrocortisone in the treatment of malignant hyperthermia. Flumazenil is an antidote for benzodiazepine overdose, while N-acetylcysteine is an antidote for paracetamol overdose.

Understanding Neuromuscular Blocking Drugs

Neuromuscular blocking drugs are commonly used in surgical procedures as an adjunct to anaesthetic agents. These drugs are responsible for inducing muscle paralysis, which is a necessary prerequisite for mechanical ventilation. There are two types of neuromuscular blocking drugs: depolarizing and non-depolarizing.

Depolarizing neuromuscular blocking drugs bind to nicotinic acetylcholine receptors, resulting in persistent depolarization of the motor end plate. On the other hand, non-depolarizing neuromuscular blocking drugs act as competitive antagonists of nicotinic acetylcholine receptors. Examples of depolarizing neuromuscular blocking drugs include succinylcholine (also known as suxamethonium), while examples of non-depolarizing neuromuscular blocking drugs include tubcurarine, atracurium, vecuronium, and pancuronium.

While these drugs are effective in inducing muscle paralysis, they also come with potential adverse effects. Depolarizing neuromuscular blocking drugs may cause malignant hyperthermia and transient hyperkalaemia, while non-depolarizing neuromuscular blocking drugs may cause hypotension. However, these adverse effects can be reversed using acetylcholinesterase inhibitors such as neostigmine.

It is important to note that suxamethonium is contraindicated for patients with penetrating eye injuries or acute narrow angle glaucoma, as it increases intra-ocular pressure. Additionally, suxamethonium is the muscle relaxant of choice for rapid sequence induction for intubation and may cause fasciculations. Understanding the mechanism of action and potential adverse effects of neuromuscular blocking drugs is crucial in ensuring their safe and effective use in surgical procedures.

This man has recently experienced constipation, weight loss, and one instance of blood in his stool. The most probable diagnosis for these symptoms is colorectal cancer (CRC), and further investigation should focus on confirming or ruling out CRC. According to NICE CG131 guidelines, patients without significant comorbidities should be offered a colonoscopy to diagnose CRC.

If the patient had upper GI symptoms such as dysphagia, dyspepsia, or epigastric pain, an upper GI endoscopy would be appropriate. A Faecal Occult Blood Test (FOBT) would have been suitable for screening purposes, as is currently done in the UK. An abdominal X-ray is not necessary as there is no evidence to suggest a likely diagnosis of bowel obstruction, infarction, or perforation that would require X-ray imaging.

Referral Guidelines for Colorectal Cancer

Colorectal cancer is a serious condition that requires prompt diagnosis and treatment. In 2015, the National Institute for Health and Care Excellence (NICE) updated their referral guidelines for patients suspected of having colorectal cancer. According to these guidelines, patients who are 40 years or older with unexplained weight loss and abdominal pain, 50 years or older with unexplained rectal bleeding, or 60 years or older with iron deficiency anemia or change in bowel habit should be referred urgently to colorectal services for investigation. Additionally, patients who test positive for occult blood in their feces should also be referred urgently.

An urgent referral should also be considered for patients who have a rectal or abdominal mass, unexplained anal mass or anal ulceration, or are under 50 years old with rectal bleeding and any of the following unexplained symptoms/findings: abdominal pain, change in bowel habit, weight loss, or iron deficiency anemia.

The NHS offers a national screening program for colorectal cancer, which involves sending eligible patients aged 60 to 74 years in England and 50 to 74 years in Scotland FIT tests through the post. FIT is a type of fecal occult blood test that uses antibodies to detect and quantify the amount of human blood in a single stool sample. Patients with abnormal results are offered a colonoscopy.

The FIT test is also recommended for patients with new symptoms who do not meet the 2-week criteria listed above. For example, patients who are 50 years or older with unexplained abdominal pain or weight loss, under 60 years old with changes in their bowel habit or iron deficiency anemia, or 60 years or older who have anemia even in the absence of iron deficiency. Early detection and treatment of colorectal cancer can significantly improve patient outcomes, making it important to follow these referral guidelines.

After experiencing a sudden and severe headache known as a thunderclap headache, a subarachnoid haemorrhage was diagnosed through CT scans that revealed fresh blood in the subarachnoid space. Given the patient’s history of ADPKD, which is associated with Berry aneurysms, it is likely that the haemorrhage was caused by an aneurysm. The most appropriate treatment for such an aneurysm is now considered to be coiling by an interventional neuroradiologist. This is a preferred method over neurosurgical procedures such as aneurysm clipping or haematoma evacuation via craniotomy, which are reserved for specific cases. Thrombectomy, on the other hand, is used to manage acute ischaemic stroke, while external ventricular drains are used to treat complications such as hydrocephalus and are not directly related to treating the aneurysm itself.

A subarachnoid haemorrhage (SAH) is a type of bleeding that occurs within the subarachnoid space of the meninges in the brain. It can be caused by head injury or occur spontaneously. Spontaneous SAH is often caused by an intracranial aneurysm, which accounts for around 85% of cases. Other causes include arteriovenous malformation, pituitary apoplexy, and mycotic aneurysms. The classic symptoms of SAH include a sudden and severe headache, nausea and vomiting, meningism, coma, seizures, and ECG changes.

The first-line investigation for SAH is a non-contrast CT head, which can detect acute blood in the basal cisterns, sulci, and ventricular system. If the CT is normal within 6 hours of symptom onset, a lumbar puncture is not recommended. However, if the CT is normal after 6 hours, a lumbar puncture should be performed at least 12 hours after symptom onset to check for xanthochromia and other CSF findings consistent with SAH. If SAH is confirmed, referral to neurosurgery is necessary to identify the underlying cause and provide urgent treatment.

Management of aneurysmal SAH involves supportive care, such as bed rest, analgesia, and venous thromboembolism prophylaxis. Vasospasm is prevented with oral nimodipine, and intracranial aneurysms require prompt intervention to prevent rebleeding. Most aneurysms are treated with a coil by interventional neuroradiologists, but some require a craniotomy and clipping by a neurosurgeon. Complications of aneurysmal SAH include re-bleeding, hydrocephalus, vasospasm, and hyponatraemia. Predictive factors for SAH include conscious level on admission, age, and amount of blood visible on CT head.

Complications of Colles’ Fracture

Colles’ fracture is a type of fracture that occurs at the lower end of the radius, often accompanied by a fracture of the ulnar styloid process. It is commonly seen in elderly women who fall on their outstretched hand. While this type of fracture can be treated, there are three main complications that can arise.

The first complication is malunion, which occurs when the displacement is not fully corrected during manipulation. This can lead to deformity and limited wrist movements, delayed rupture of the extensor tendon, and carpal tunnel syndrome. The second complication is stiffness of the fingers and wrist, which can occur if the finger joints are not exercised during the immobilization period. Finally, Sudeck’s atrophy is a rare complication that causes severe pain in the hand and wrist, swelling, and circulatory disturbance in the hand with oedema, resulting in painful stiffness of all joints of the hands.

It is important to be aware of these complications when treating Colles’ fracture to ensure proper healing and prevent long-term issues.

The patient’s pre-operative morbidity is assessed using the ASA scoring system, which takes into account various factors including BMI. Despite having no significant medical history and not smoking or drinking, the patient’s BMI is elevated and can be rounded up to 35 kg/m², placing her in the ASA II category. This category includes patients with a BMI between 30 and 40. A healthy patient who does not smoke or drink and has a BMI below 30 kg/m² is classified as ASA I. Patients with severe systemic diseases such as poorly controlled diabetes, hypertension, chronic obstructive pulmonary disease, or morbid obesity (BMI > 40 kg/m²) are classified as ASA III. ASA IV is reserved for patients with severe systemic diseases that pose a constant threat to life, such as ongoing cardiac ischaemia or recent myocardial infarction, sepsis, and end-stage renal disease.

The American Society of Anaesthesiologists (ASA) classification is a system used to categorize patients based on their overall health status and the potential risks associated with administering anesthesia. There are six different classifications, ranging from ASA I (a normal healthy patient) to ASA VI (a declared brain-dead patient whose organs are being removed for donor purposes).

ASA II patients have mild systemic disease, but without any significant functional limitations. Examples of mild diseases include current smoking, social alcohol drinking, pregnancy, obesity, and well-controlled diabetes mellitus or hypertension. ASA III patients have severe systemic disease and substantive functional limitations, with one or more moderate to severe diseases. Examples include poorly controlled diabetes mellitus or hypertension, COPD, morbid obesity, active hepatitis, alcohol dependence or abuse, implanted pacemaker, moderate reduction of ejection fraction, End-Stage Renal Disease (ESRD) undergoing regularly scheduled dialysis, history of myocardial infarction, and cerebrovascular accidents.

ASA IV patients have severe systemic disease that poses a constant threat to life, such as recent myocardial infarction or cerebrovascular accidents, ongoing cardiac ischemia or severe valve dysfunction, severe reduction of ejection fraction, sepsis, DIC, ARD, or ESRD not undergoing regularly scheduled dialysis. ASA V patients are moribund and not expected to survive without the operation, such as ruptured abdominal or thoracic aneurysm, massive trauma, intracranial bleed with mass effect, ischaemic bowel in the face of significant cardiac pathology, or multiple organ/system dysfunction. Finally, ASA VI patients are declared brain-dead and their organs are being removed for donor purposes.

Elective laparoscopic cholecystectomy is the preferred treatment for biliary colic.

Biliary colic is typically characterized by worsening pain after eating, but the patient is generally in good health, has no fever, and has a soft abdomen. In contrast, cholecystitis is associated with signs of infection, such as fever and tachycardia, and may involve palpable gallbladder and positive Murphy’s sign. If the patient is clinically stable and a good candidate for surgery, elective cholecystectomy is the appropriate management option. Cholecystostomy is reserved for cases of acute cholecystitis with pus accumulation, while ERCP is used to remove obstructing gallstones in patients with jaundice or risk of ascending cholangitis. MRCP is a diagnostic tool and not a treatment option.

Biliary colic is a condition that occurs when gallstones pass through the biliary tree. The risk factors for this condition are commonly referred to as the ‘4 F’s’, which include being overweight, female, fertile, and over the age of forty. Other risk factors include diabetes, Crohn’s disease, rapid weight loss, and certain medications. Biliary colic occurs due to an increase in cholesterol, a decrease in bile salts, and biliary stasis. The pain associated with this condition is caused by the gallbladder contracting against a stone lodged in the cystic duct. Symptoms include right upper quadrant abdominal pain, nausea, and vomiting. Diagnosis is typically made through ultrasound. Elective laparoscopic cholecystectomy is the recommended treatment for biliary colic. However, around 15% of patients may have gallstones in the common bile duct at the time of surgery, which can result in obstructive jaundice. Other possible complications of gallstone-related disease include acute cholecystitis, ascending cholangitis, acute pancreatitis, gallstone ileus, and gallbladder cancer.